Jane Street’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.23M Sell
725,003
-43,952
-6% -$190K ﹤0.01% 4879
2025
Q4
$2.74M Buy
768,955
+550,738
+252% +$3.37M ﹤0.01% 4205
2025
Q3
$1.94M Buy
218,217
+200,536
+1,134% +$2.03M ﹤0.01% 5000
2025
Q2
$163K Buy
+17,681
New +$151K ﹤0.01% 8685
2025
Q1
Sell
-104,697
Closed -$989K 9411
2024
Q4
$1.12M Buy
104,697
+42,282
+68% +$325K ﹤0.01% 5147
2024
Q3
$355K Sell
62,415
-119,531
-66% -$690K ﹤0.01% 7761
2024
Q2
$768K Buy
181,946
+137,046
+305% +$554K ﹤0.01% 6285
2024
Q1
$229K Sell
44,900
-67,410
-60% -$379K ﹤0.01% 7989
2023
Q4
$1.05M Buy
112,310
+30,059
+37% +$207K ﹤0.01% 5494
2023
Q3
$539K Sell
82,251
-352,041
-81% -$2.8M ﹤0.01% 6185
2023
Q2
$3.53M Buy
434,292
+413,231
+1,962% +$3.54M ﹤0.01% 3245
2023
Q1
$180K Buy
21,061
+7,293
+53% +$72.8K ﹤0.01% 7910
2022
Q4
$127K Sell
13,768
-8,352
-38% -$89.2K ﹤0.01% 7971
2022
Q3
$228K Buy
22,120
+3,123
+16% +$33K ﹤0.01% 7973
2022
Q2
$190K Sell
18,997
-72,806
-79% -$690K ﹤0.01% 8238
2022
Q1
$1.13M Sell
91,803
-60,333
-40% -$742K ﹤0.01% 5882
2021
Q4
$2.64M Sell
152,136
-51,953
-25% -$987K 0.01% 3932
2021
Q3
$3.66M Sell
204,089
-1,361
-0.7% -$27.1K 0.01% 3280
2021
Q2
$4.7M Buy
205,450
+124,941
+155% +$1.85M 0.01% 2744
2021
Q1
$1.2M Buy
80,509
+70,078
+672% +$765K ﹤0.01% 5095
2020
Q4
$57K Sell
10,431
-43,612
-81% -$230K ﹤0.01% 7299
2020
Q3
$246K Buy
+54,043
New +$233K ﹤0.01% 6160
2019
Q3
Sell
-142,349
Closed -$480K 5045
2019
Q2
$480K Buy
142,349
+129,673
+1,023% +$403K ﹤0.01% 3631
2019
Q1
$39K Buy
+12,676
New +$30.3K ﹤0.01% 4851
2018
Q3
Sell
-59,805
Closed -$157K 5068
2018
Q2
$157K Buy
+59,805
New +$167K ﹤0.01% 4645
2017
Q2
Hold
0
4310
2017
Q1
Hold
0
4107
2016
Q2
Sell
-10,047
Closed -$49K 4049
2016
Q1
$49K Sell
10,047
-129,559
-93% -$570K ﹤0.01% 3951
2015
Q4
$778K Buy
+139,606
New +$993K 0.01% 2005

Other funds holding AVXL